JAMA Network podcast

JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

2024-10-24
0:00
20:41
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

Fler avsnitt från "JAMA Network"